Ki Summary

Reaction Details

Report a problem with these data

Target

Gastrin/cholecystokinin type B receptor

Ligand

BDBM50045813

Substrate/Competitor

n/a

Meas. Tech.

ChEBML_49880

79±n/a nM

Citation

Blommaert, AG; Weng, JH; Dorville, A; McCort, I; Ducos, B; Durieux, C; Roques, BP Cholecystokinin peptidomimetics as selective CCK-B antagonists: design, synthesis, and in vitro and in vivo biochemical properties. J Med Chem36:2868-77 (1993) [PubMed]

More Info.:

Get all data from this article, Assay Method

Gastrin/cholecystokinin type B receptor

Name:

Gastrin/cholecystokinin type B receptor

Synonyms:

Type:

G Protein-Coupled Receptor (GPCR)

Mol. Mass.:

48445.79

Organism:

Homo sapiens (Human)

Description:

Stable expression of human CCK-2 receptors in HEK 293 cells.

Residue:

447

Sequence:

MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITL
YAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTF
IFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWL
LSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGL
ISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRS
RPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDG
PGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRAL
PDEDPPTPSIASLSRLSYTTISTLGPG

BDBM50045813

n/a

Name

BDBM50045813

Synonyms:

CHEMBL328852 | {2-(1H-Indol-3-yl)-1-methyl-1-[2-(4-nitro-phenyl)-ethylcarbamoyl]-ethyl}-carbamic acid adamantan-2-yl ester

Type

Small organic molecule

Emp. Form.

C31H36N4O5

Mol. Mass.

544.6413

SMILES

CC(Cc1c[nH]c2ccccc12)(NC(=O)OC1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2)C(=O)NCCc1ccc(cc1)[N+]([O-])=O |wU:17.29,wD:21.28,19.20,23.26,TLB:25:21:24:16.17.18,15:16:22:19.24.20,THB:18:17:22:19.24.20,18:19:16.17.25:22,(14.54,-5.88,;13.21,-6.66,;11.91,-7.44,;11.91,-8.98,;12.82,-10.22,;11.91,-11.48,;10.44,-11.01,;9.11,-11.78,;7.78,-11.01,;7.78,-9.47,;9.11,-8.69,;10.44,-9.46,;11.72,-6.25,;10.39,-5.48,;9.29,-6.56,;9.99,-3.99,;8.5,-3.59,;6.75,-3.6,;5.7,-4.64,;4.42,-3.99,;3.86,-2.59,;4.98,-1.54,;6.61,-1.38,;7.17,-2.8,;6.03,-3.9,;6.19,-2.31,;14.57,-7.42,;14.54,-8.96,;16.11,-7.42,;16.85,-6.09,;18.39,-6.09,;19.16,-4.74,;20.7,-4.76,;21.47,-3.43,;20.7,-2.08,;19.16,-2.1,;18.39,-3.43,;21.47,-.75,;22.71,-1.5,;21.47,.7,)|

Structure